Stockfry.comSAS Online Stock Trading, Demat, Brokerage and Reviews  Rs 999 Unlimited Trades
Enquire Now

Nectar Lifesciences Ltd BSE:532649 NSE:NECLIFE

Company is listed on both NSE and BSE. NSE symbol for Nectar Lifesciences Ltd is 'NECLIFE' and BSE code for Nectar Lifesciences Ltd is '532649'.

About Company

Nectar Lifesciences Ltd. (Nectar) is an India-based company engaged in the manufacture of active pharmaceutical ingredients that include semi-synthetic penicillin (SSP), and cephalosporin range of oral and sterile bulk drugs. The Company`s oral cephalosporin products include cefixime, cefdinir, cefuroxime axetil (crystalline and amorphous), cefprozil monohydrate and cefpodoxime proxetil. It offers sterile cephalosporins products, such as cefotaxime sodium, ceftriaxone sodium, cefazoline sodium, cefoperazone sodium, and ceftazidime, ceftazidime and cefpirome for injection. Nectar`s oral SSP products include ampicillin trihydrate, ampicillin anhydrous, amoxicillin trihydrate, cloxacillin sodium, flucloxacillin sodium and dicloxacillin sodium. The Company offers sterile SSP products, such as ampicillin sodium, amoxicillin sodium, cloxacillin sodium, flucloxacillin sodium and sulbactam sodium. Its other products include chloramphenicol sodium succinate, clarithromycin and atorvastatin.

Nectar Lifesciences Ltd Stock Quotes and Charts

Symbol Last Trade on
Change Volume
  Today's
Open High Low
  Previous Day's   52 Weeks
Close Low - High
  Website   http://www.neclife.com
  Industry*   
  Corporate Action  Detail/More>>
  Ex_Date:21-Sep-2011    Purpose:ANNUAL GENERAL MEETING AND DIVIDEND RE.0.10 PER SHARE

  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • iCharts.in

Nectar Lifesciences Ltd User Reviews

avatar
3. News  Aug 26, 2008 1:02:17 AM IST Reply

Pharmaceutical major Nectar Lifesciences on Monday said it will raise 50 million dollar through the issue of securities in international markets. <br><br>The board of directors of the company at its meeting today approved to issue Global Depository Receipts (GDRs), American Depository Receipts (ADRs) or any other international offering of up to 50 million US dollars, the company said in a filing to the Bombay Stock Exchange. <br><br>Meanwhile, the company has received board of directors approval for issue of equity shares to Citi Venture Capital International and Everest Capital (M) Ltd and would sign a non binding term in this regard.

avatar
2. Chockalingam.R  Dec 6, 2009 9:14:45 PM IST Reply

We urgently require Cefprozil monohydrate 35kg. Please Quote your Best Price.<br><br>Thanks

avatar
1. tilak   Oct 1, 2010 3:02:07 AM IST Reply

The company had a not so good quarter this time and so the share price has fallen. Things will improve and the stock will reach Rs40 levels easily and then maybe higher if the results are good.Promoter buying is a very positive sign. Not much downside from here.

ProStocks, The Flat Rate Discount Stock Broker

Fix Price - Rs 15 Per Trade


Rs 899/Month,8999/Year for
Equity Cash and F&O

Rs 499/Month,4999/Year for
Currency Derivatives

Lowest Transaction Charge
Lowest Call & Trade Fee
Lowest Stamp Duty

Get FREE Trading + Demat Acct

Zerodha  Zerodha

Free Equity Delivery Trades
Flat Rs 20 Per Trade for F&O




SAS Online Stock Trading, Demat, Brokerage and Reviews  SAS Online

Rs 999 for Unlimited Trading

Get Free Trading Account

Ventura

Brokerage: Intraday @ 0.02%, Delivery @ 0.15%

Rs 0 account opening fee
(400 Rs waived)

Sharekhan

Beginner, seasoned investor, active trader or HNI. Get customised solutions.

Rs 0 account opening fee on Online Trading and a Demat Account
(Rs 1150 waived)


Search topsharebrokers.com:

Translate topsharebrokers.com: